Juha-Matti Hyttinen

Title: Juha-Matti Hyttinen: Innovator in Biologically Active Polypeptides

Introduction

Juha-Matti Hyttinen is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of biotechnology, particularly in the production of biologically active polypeptides. His innovative methods have the potential to enhance the efficiency and safety of protein production in transgenic mammals.

Latest Patents

Hyttinen holds a patent for a method that facilitates the production of biologically active polypeptides in the milk of transgenic non-human mammals. This process involves creating a fusion protein that can be cleaved to release the desired protein or polypeptide. The method aims to reduce or prevent side effects associated with ectopic expression or leakage of the protein. One example of such a fusion protein is β-lactoglobulin-EPO, which allows for the release of biologically active EPO upon cleavage.

Career Highlights

Juha-Matti Hyttinen has been associated with Pharming B.V., a company that focuses on developing innovative protein therapies. His work at Pharming has been instrumental in advancing the field of recombinant protein production. His expertise in biotechnology and transgenic technology has positioned him as a key figure in this area.

Collaborations

Hyttinen collaborates with Veli-Pekka Korhonen, contributing to the advancement of their shared research interests in biotechnology and protein production.

Conclusion

Juha-Matti Hyttinen's innovative work in the production of biologically active polypeptides represents a significant advancement in biotechnology. His contributions have the potential to improve therapeutic protein production, making a lasting impact in the field.